Using circulating tumor DNA in colorectal cancer: current and evolving practices

M Malla, JM Loree, PM Kasi, AR Parikh - Journal of Clinical Oncology, 2022 - ascopubs.org
There exists a tremendous opportunity in identifying and determining the appropriate
predictive and prognostic biomarker (s) for risk stratification of patients with colorectal …
被引用次数：138 相关文章

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

M Malla, JM Loree, PM Kasi, AR Parikh - Journal of Clinical Oncology, 2022 - cir.nii.ac.jp
抄録< jats: p> There exists a tremendous opportunity in identifying and determining the
appropriate predictive and prognostic biomarker (s) for risk stratification of patients with …
[HTML] nih.gov

[HTML][HTML] Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

M Malla, JM Loree, PM Kasi… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
There exists a tremendous opportunity in identifying and determining the appropriate
predictive and prognostic biomarker (s) for risk stratification of patients with colorectal …

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices.

M Malla, JM Loree, PM Kasi… - Journal of Clinical …, 2022 - europepmc.org
There exists a tremendous opportunity in identifying and determining the appropriate
predictive and prognostic biomarker (s) for risk stratification of patients with colorectal …

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

M Malla, JM Loree, PM Kasi… - Journal of Clinical …, 2022 - ingentaconnect.com
There exists a tremendous opportunity in identifying and determining the appropriate
predictive and prognostic biomarker (s) for risk stratification of patients with colorectal …

Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

M Malla, JM Loree, PM Kasi… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
There exists a tremendous opportunity in identifying and determining the appropriate
predictive and prognostic biomarker (s) for risk stratification of patients with colorectal …